{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:41:51Z","timestamp":1759938111548},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1006\/gyno.2002.6746","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T14:27:09Z","timestamp":1032186429000},"page":"118-123","source":"Crossref","is-referenced-by-count":58,"title":["Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Carcinoma"],"prefix":"10.1006","volume":"86","author":[{"given":"Anita S.Y","family":"Sit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesmary","family":"Modugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel L","family":"Weissfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L","family":"Berga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta B","family":"Ness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2002.6746_RF1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0029-7844(95)00429-7","article-title":"Menopause and hormone replacement therapy: An overview","volume":"87","author":"Hammond","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","article-title":"The effect of postmenopausal estrogen therapy on bone mineral density in elderly women","volume":"329","author":"Felson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2002.6746_RF3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Post menopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstern","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2002.6746_RF4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1992.tb13732.x","article-title":"Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis","volume":"99","author":"Ryan","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1006\/gyno.2002.6746_RF5","first-page":"711","article-title":"Determinants of ovarian cancer risk. I. Reproductive experience and family history","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2002.6746_RF6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1996.0315","article-title":"Estrogen replacement therapy and risk of epithelial ovarian cancer","volume":"63","author":"Risch","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6746_RF7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ijc.2910550312","article-title":"Reproductive variables, tobacco, ethanol, coffee, and somatometry as risk factors for ovarian cancer","volume":"55","author":"Polychronopoulou","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2002.6746_RF8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies, II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/oxfordjournals.aje.a115441","article-title":"Noncontraceptive estrogen use and epithelial ovarian cancer","volume":"140","author":"Kaufman","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF10","first-page":"1142","article-title":"An epidemiologic study of epithelial carcinoma of the ovary","volume":"130","author":"Hildreth","year":"1981","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: A case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2002.6746_RF12","first-page":"95","article-title":"Noncontraceptive estrogen use and the occurrence of ovarian cancer","volume":"68","author":"Weiss","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2002.6746_RF13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0029-7844(97)00118-X","article-title":"Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study","volume":"June","author":"Hempling","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF14","article-title":"Menopause and ovarian cancer","volume":"127","author":"Hartge","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1097-0142(197902)43:2<723::AID-CNCR2820430248>3.0.CO;2-1","article-title":"Ovarian cancer: Incidence and case-control study","volume":"43","author":"Annergers","year":"1979","journal-title":"Cancer"},{"key":"10.1006\/gyno.2002.6746_RF16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0895-4356(99)00179-1","article-title":"A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer","volume":"53","author":"Coughlin","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0029-7844(98)00139-2","article-title":"Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis","volume":"92","author":"Garg","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<848::AID-IJC8>3.0.CO;2-E","article-title":"Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies","volume":"80","author":"Negri","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2002.6746_RF19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0002-9378(75)90509-8","article-title":"The etiology and prevention of ovarian cancer","volume":"123","author":"Stadel","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014A factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1006\/gyno.2002.6746_RF21","first-page":"209","article-title":"Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism","volume":"10","author":"Goodman","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1006\/gyno.2002.6746_RF22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00016348409156709","article-title":"Estradiol and progesterone receptors in normal ovary and ovarian tumors","volume":"63","author":"Lantta","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1006\/gyno.2002.6746_RF23","first-page":"717","article-title":"Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2002.6746_RF24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1071-5576(00)00049-6","article-title":"Comparison of pharmokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women","volume":"May\u2013Jun","author":"Bhavnani","year":"2000","journal-title":"J Soc Gynecol Invest"},{"key":"10.1006\/gyno.2002.6746_RF25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00042192-200007040-00006","article-title":"Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: Associations with sex hormone-binding globulin, estradiol, estrone levels","volume":"7","author":"Nachtigall","year":"2000","journal-title":"Menopause"},{"key":"10.1006\/gyno.2002.6746_RF26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/cmt.4.1.42.48","article-title":"Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens","volume":"March","author":"Lundstrom","year":"2001","journal-title":"Climacteric"},{"key":"10.1006\/gyno.2002.6746_RF27","first-page":"13","article-title":"Conjugated estrogens and breast cancer risk","volume":"13","author":"Campagnoli","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1006\/gyno.2002.6746_RF28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF29","series-title":"Case-Control Studies. Design, Conduct, Analysis","author":"Schlesselman","year":"1982"},{"key":"10.1006\/gyno.2002.6746_RF30","first-page":"5849","article-title":"Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones","volume":"48","author":"Harlow","year":"1998","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2002.6746_RF31","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women","volume":"285","author":"Rodriguez","year":"2001","journal-title":"JAMA"},{"key":"10.1006\/gyno.2002.6746_RF32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6690731","article-title":"Hormone replacement therapy and risk of epithelial ovarian cancer","volume":"81","author":"Purdie","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2002.6746_RF33","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1073\/pnas.96.10.5722","article-title":"Expression of human estrogen receptor-\u03b1 and -\u03b2, progesterone receptor and androgen receptor mRNA in normal and malignant ovarian epithelial cells","volume":"96","author":"Lau","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2002.6746_RF34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(96)00216-8","article-title":"Estrogen action in human ovarian cancer","volume":"25","author":"Clinton","year":"1997","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1006\/gyno.2002.6746_RF35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9378(95)90176-0","article-title":"Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro","volume":"173","author":"Karlan","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00006250-198906000-00021","article-title":"Estrogen and antiestrogen effects on the growth of human epithelial ovarian cancer in vitro","volume":"73","author":"Nash","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6746_RF37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0090-8258(92)90230-G","article-title":"Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth","volume":"46","author":"Wimalasena","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6746_RF38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/gyno.2001.6221","article-title":"Inhibitory effects of 17 beta-estradiol and progesterone on ovarian carcinoma cell proliferation: A potential role for inducible nitric oxide synthase","volume":"Jul","author":"Bechtel","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6746_RF39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/gyno.2001.6219","article-title":"Production of steroids by human ovarian surface epithelial cells in culture: possible role of progesterone as growth inhibitor","volume":"82","author":"Ivarasson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6746_RF40","series-title":"Treatment of the Postmenopausal Woman: Basic and Clinical Aspects","first-page":"421","article-title":"Regimens for today and the future","author":"Samsioe","year":"1994"},{"key":"10.1006\/gyno.2002.6746_RF41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3181\/00379727-217-44199","article-title":"Pharmokinetics and pharmacodynamics of conjugated equine estrogens: A chemistry and metabolism","volume":"Jan","author":"Bhavnani","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1006\/gyno.2002.6746_RF42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/jc.81.4.1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/gyno.2002.6746_RF43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oxfordjournals.aje.a117518","article-title":"Estrogen replacement therapy and fatal ovarian cancer","volume":"141","author":"Rodriguez","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00001648-199905000-00012","article-title":"Agreement of self-reported use of menopausal hormone replacement therapy with physician reports","volume":"May","author":"Jain","year":"1999","journal-title":"Epidemiology"},{"key":"10.1006\/gyno.2002.6746_RF45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1071-5576(98)00017-3","article-title":"Effect of progestin on the ovarian epithelium of macaques: Cancer prevention through apoptosis?","volume":"5","author":"Rodriguez","year":"1998","journal-title":"J Soc Gynecol Invest"},{"key":"10.1006\/gyno.2002.6746_RF46","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1944::AID-CNCR15>3.0.CO;2-V","article-title":"Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines","volume":"79","author":"Bu","year":"1997","journal-title":"Cancer"},{"key":"10.1006\/gyno.2002.6746_RF47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/oxfordjournals.aje.a114463","article-title":"Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer?","volume":"124","author":"Weiss","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2002.6746_RF48","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.274.24.1926","article-title":"Serum gonadotropins and steroid hormones and the development of ovarian cancer","volume":"274","author":"Helzlsouer","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1006\/gyno.2002.6746_RF49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","article-title":"Risk factors for epithelial borderline ovarian tumors results of a Swedish case-control study","volume":"83","author":"Riman","year":"2001","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802967466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802967466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T13:57:06Z","timestamp":1554818226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825802967466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0090825802967466"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2002.6746","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}